Profound Medical 's (PROF) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Profound Medical Corp   (NASDAQ: PROF)
 



  Profound Medical Corp Outlook

On January 3 2024 the Profound Medical Corp provided following guidance

Profound Medical Corp. (NASDAQ: PROF; TSX: PRN) announced its preliminary unaudited revenues for the fourth quarter and full year of 2023. As a leading medical device company, Profound specializes in the development and marketing of customizable, incision-free therapies for the ablation of diseased tissue. The company also provided an update on the commercialization progress of TULSA-PRO in the United States.

Due to the significant time gap between planned investment community meetings and the reporting of final 2023 results in March 2024, Profound chose to release this information. This will coincide with various investor events, including the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.